BACKGROUND: Long-term patency of extracranial-to-intracranial (EC-IC) vein bypass is poorly understood. OBJECTIVE: We report our experience of patency of arterial pedicle grafts and interposition vein grafts for the purpose of EC-IC bypass. METHODS: We analyzed 294 consecutive patients who underwent 178 intracranial arterial pedicle bypass procedures and 152 intracranial vein bypass procedures. Bypass patency was assessed by digital subtraction angiography, computed tomographic angiography, and/or Doppler ultrasound. The modified Rankin Scale (mRS) was assigned for clinical grading at the last follow-up consultation. RESULTS: The main indication for arterial pedicle bypass surgery was internal carotid artery occlusion (79 cases); for vein bypass surgery, it was giant aneurysms (61 cases). Procedure-related complications due to surgery occurred in 3 cases (1.7%; 95% CI: 0.4-5.1%) of arterial pedicle bypass surgery and 12 cases (7.9%; 95% CI: 4.5-13.4%) of vein bypass surgery. The patency rate at 6 weeks was 98% (95% CI: 95.0-99.7%) for arterial pedicle bypass and 93% (95% CI: 87.4-96%) for vein bypass, with almost all graft failures occurring within the first week following surgery. Beyond the first week, bypass patency was similar for both groups, with both arterial pedicle grafts and vein bypass grafts that were patent at 1 week having a long-term patency of 99%. There was no statistically significant difference in early, late, and overall patency between the 2 bypass groups. CONCLUSION: The surgical complication rate was greater for vein bypass. Both arterial pedicle and vein bypass have good long-term patency.
T he role of extracranial-to-intracranial (EC-IC) bypass surgery has not been established by class 1 or 2 evidence for any broad category of adult intracranial vascular pathological states. 1 However, supporting evidence for bypass surgery can be found in case series in the treatment of selected patients. [2] [3] [4] [5] Once it has been determined that intracranial bypass surgery is appropriate in an individual case, the choice of procedure is determined by the short-term requirements (eg, blood flow deemed necessary, available conduits, anticipated period of vessel occlusion during the performance of the surgical anastomosis, anticipated response to the new border zone, technical complexity), the risk of surgery, and the long-term expectations of graft patency. 6 For aortocoronary bypass, long-term patency of the internal mammary artery (as a pedicle to the coronary arteries) is superior to that of interposition saphenous vein bypass. 7, 8 However, the vascular hemodynamic environment in coronary artery surgery differs significantly from that of the low-resistance intracranial circulation. Therefore, extrapolation of the superiority of arterial conduit bypass over that of interposition saphenous vein graft, when considering the intracranial circulation, may be erroneous.
The Mayo Clinic series suggests that long-term patency of saphenous vein bypass intracranially exceeded vein graft bypass for aorto-coronary or peripheral vascular surgery grafts. 9 Furthermore, recent innovations, such as excimer laser-assisted nonocclusive EC-IC bypasses, make it timely to review the longterm patency of interposition venous conduits for bypass into the intracranial circulation. 10 In this article, we compare vein bypass with that of intracranial arterial pedicle graft to explore the longterm robustness of intracranial venous bypass.
We analyzed results of our patients who underwent cerebral revascularization bypass between January 1990 and June 2010 to determine long-term graft patency of interposition saphenous vein bypass graft between the extracranial circulation and the intracranial circulation.
METHODS
Between January 1990 and June 2010, we prospectively collected and analyzed data on 294 consecutive patients (154 male and 140 female) undergoing cerebrovascular bypass. This study was approved by the Macquarie University Human Research Ethics Committee, and performed in accordance with institutional ethics committee guidelines.
We recorded demographics, clinical indications, and radiological and treatment-related information.
Bypass Technique
The technique and early results have been reported in previous publications.
11 -15 In brief, all patients were given 150 mg aspirin on the morning of surgery. The superficial temporal artery (STA) was prepared and harvested with a standard operative procedure for STA-to-middle cerebral artery (MCA) bypass.
Vein bypass between the common carotid artery (CCA) and intracranial internal carotid artery (ICA) or MCA was carried out via an exposure of the CCA, ICA, and external carotid artery (ECA) via an anterior sternomastoid approach (this was contralateral to the targeted distal anastomosis in one case of CCA occlusion), followed by an orbitozygomatic craniotomy. The roof and lateral wall of the orbit were removed, and the dura was opened and reflected on the superior orbital fissure. The sylvian fissure was widely split, the basal cisterns were opened, and the intracranial ICA (or MCA) exposed. Great care was taken when splitting the sylvian fissure to avoid damaging the pia, because the patient had been given aspirin and heparin was to be used at the time of the proximal anastomosis. If retraction of the frontal or temporal lobe was necessary, the retraction was gently continued during the early part of the surgery when mannitol (1 g/kg) was producing its effective relaxation. A subcutaneous tunnel anterior to the ear was created with a large-bore tunneler. The vein, selected for its even caliber by preoperative venous duplex ultrasound, usually was harvested from the long saphenous vein below the knee. The vein was harvested and distended immediately before it was needed for distal anastomosis to ensure that ischemia of the venous endothelium lasted for the minimum length of time. The vein was then positioned between the CCA and the intended distal anastomotic site via the large-bore subcutaneous tunnel. The vein was distended again within the tunnellar to ensure it was not twisted. The caliber of the tunnellar had to be large enough not to impede the rotation of the vein during this inflation and thus prevent any twisting of the vein in its subcutaneous site. The distal anastomosis was performed before the proximal anastomosis, because the distal anastomosis was more difficult. This ensured that the vein would be slack enough to allow it to be maneuvered as required during the difficult suturing. The length of the vein was determined when performing the proximal anastomosis on the CCA. The vein for the distal anastomosis was prepared by a straight, sharp cut and removal of the loose adventitia for the end-to-end anastomosis if intended for the intracranial ICA or at 45 degrees with a long fish-mouth if an end-to-side anastomosis on the MCA was planned. For anastomosis to the intracranial ICA, a permanent aneurysm clip was placed immediately distal to the ophthalmic artery, and a temporary clip was placed on the ICA immediately proximal to the posterior communicating artery (PCA) to allow for some collateral flow during cross-clamping. When there was insufficient room for the temporary clip to permit the ICA to splay open to allow for anastomosis, the temporary clip was placed more distally on the ICA (proximal to the anterior choroidal artery) and also crossing the PCA. It often became necessary to move the site of ICA division more distally from the distal dural ring of the ICA, because the senior author (MKM) has found that the ICA wall appears to dissect more easily close to the distal dural ring. When this arterial wall separation occurs, it is more difficult to achieve accurate suture placement. Division of the ICA was performed with straight scissors. When the distal anastomosis was intended for the MCA, the MCA site was selected on a straight segment of artery of sufficient length to accommodate the long fish-mouthed vein. The senior author (MKM) has experienced greater difficulty ensuring a watertight closure when the anastomosis is on the outer convexity of a curve. The MCA arteriotomy was created with a super-knife (Alcon 15°blade, Alcon Inc., Hünenberg, Switzerland) and lengthened with microscissors. Heparin was not used at this point, because the distal anastomosis is thoroughly irrigated free of blood products. Heparin, 2500 units, was administered immediately prior to the reestablishment of flow across the distal anastomosis. The distal end was sutured with interrupted 8-0 sutures on the intracranial ICA and 9-0 sutures for the MCA. Although we have used continuous suturing in some cases, the time gained with the running stitch can be lost with correcting errors of tension that allow suture-line leakages following cross-clamp release.
After the distal anastomosis was completed, the proximal anastomosis was performed on the distal CCA with an arteriotomy to accommodate the 45-degree angle cut of the vein and the long fish-mouth. Suturing was performed with a running 7-0 stitch. Before flow was established in the vein bypass, the vein was de-aired with a 25-gauge needle hole at its highest point. Blood flow in the vein bypass and suture line security were checked with Doppler ultrasound and visually. In most cases, following establishment of bypass flow, the ICA was almost completely ligated at its origin (a small amount of flow was allowed to continue to perfuse the ophthalmic artery).
In the case of bypass to the upper posterior circulation, the intracranial exposure was by a subtemporal approach to the posterior cerebral artery (PCA) adhering to the principles already discussed. In most cases, the PCA is not long enough to perform a fish-mouth on the vein at this site. Retractors are necessary for PCA anastomosis. Vertebral artery anastomosis was performed with a far lateral medial transcondylar approach for an end-to-end distal anastomosis. No excimer laser-assisted nonocclusive anastomosis techniques were used in any cases in this series.
Postoperatively, bypass patency was established by digital subtraction angiography, computed tomographic angiography, or Doppler/duplex ultrasound examination at 6 weeks, 6 months, and 1 year, and at 2-yearly intervals thereafter. The clinical status of each of the 294 surgical patients was documented at 6 weeks following surgery. A good outcome was defined as a modified Rankin Scale (mRS) score of 0 or 1; adverse outcomes were considered relevant if they produced a change in mRS of more than 1 as a result of surgery. The clinical condition assigned at last follow-up was used to determine the mRS for those assessed as having sustained an adverse outcome at 6 weeks.
Patients were divided into 2 groups for analysis based on graft selection: (1) arterial pedicle bypass STA conduit; and (2) saphenous vein interposition bypass from an extracranial to an intracranial artery. Patients who had undergone bypass using radial artery as the graft and occipital-to-posterior inferior cerebellar artery anastomosis were excluded from this study, because these procedures were performed on only 6 occasions and do not fit well into either of the 2 categories. Indirect anastomoses also were excluded.
Statistics
Continuous variables are expressed as mean 6 standard deviation and categorical variables as percentages. Comparisons were made between arterial pedicle bypass and vein bypass with regard to overall patency and occlusion rates. Survival curves were created to evaluate patency rates over time using GraphPad Prism 5 for Mac OS X (GraphPad Software, Inc, LaJolla, California). Because the a priori assumption of proportional hazards could not be met, comparisons were made using the Wilcoxon test. A value of P , .05 was considered statistically significant. The modified Wald method 16 was used to calculate the 95% confidence intervals for a surgical risk proportion for downgrading following surgery.
RESULTS
In the 20 years covered by this study, a total of 294 patients with 330 cerebrovascular bypasses were analyzed. The mean age was 49 6 20 years (range, 5-87 years) for the arterial pedicle graft and 45 6 16 years (range, 9-74 years) for vein graft. This difference was not significant. There were 166 males and 128 females. Thirty-six patients had bilateral procedures; of these, 2 patients underwent 3 procedures apiece. Patients were followed for an average of 23 6 32 months (range, 0-196 months) in the case of arterial pedicle grafts and 38 6 48 months (range, 0-186 months) in the case of vein grafts. There were 178 and 152 patient procedures in the arterial pedicle and vein bypass groups, respectively. The bypass type, surgical indications, clinical characteristics, and outcomes are summarized in Table 1 .
The main indication for surgery in the 178 patients in the arterial pedicle bypass group was to augment cerebral blood flow by STA-MCA bypass for chronic hemodynamic ischemia such as ICA occlusion (79 patients), moyamoya disease (58 patients), and MCA occlusion or stenosis (26 patients). Other arterial pedicle bypasses were performed in conjunction with planned vessel sacrifice for aneurysm and tumor in 14 patients. In addition, 1 STA-PCA bypass was performed for chronic hemodynamic ischemia due to vertebral artery occlusion.
In the vein bypass group, 152 saphenous vein graft (SVG) conduits were created, as follows:
86 (57%) CCA-to-intracranial ICA bypasses; 37 (24%) CCA-to-MCA bypasses; 15 (9.9%) CCA-to-intracranial vertebral artery bypasses; 14 (9.2%) CCA-to-PCA bypasses. Broadly defined, the indications for surgery were to allow planned vessel sacrifice (n = 105), augmentation of cerebral blood flow in the presence of chronic hemodynamic ischemia (n = 24), and emergency revascularization surgery for stroke in evolution (n = 23).
For the 105 surgeries that fell into the broad category of planned vessel sacrifice, the specific indications were as follows:
to facilitate the exclusion of an aneurysm: 61 procedures; to facilitate the exclusion of a diseased artery identified as presenting a risk of stroke, eg, arterial dissecting aneurysm: 38 procedures; to facilitate resection of tumor: 6 procedures. Of the 38 vein bypasses performed for the purpose of excluding a diseased artery identified as presenting a risk of stroke, 35 were performed in cases of dissecting aneurysms, and 3 were performed in cases with bilateral vertebrobasilar occlusive disease and recurrent transient ischemic attacks.
Vein bypass for augmentation of cerebral blood flow was performed in 24 patients with chronic hemodynamic ischemia. Eighteen patients in this category were suffering from crescendo vertebrobasilar insufficiency symptoms despite maximal medical therapy. Four patients underwent vein bypass with symptomatic chronic ICA occlusion because they were unsuitable candidates for STA-MCA surgery due to previous loss of CCA or ECA. None of the 24 patients with chronic hemodynamic ischemia developed stroke, either radiological or clinical, as a consequence of inadequate blood flow to the revascularized territory. All patients remained neurologically intact following surgery.
In addition to planned vessel sacrifice, emergency revascularization surgery for stroke in evolution was performed in 23 patients. Among these, 20 procedures were performed as a consequence of technical problems encountered during aneurysm clipping. The other 3 cases presented with symptomatic ischemic symptoms suggesting early infarction due to high-grade stenosis from ICA dissections and poor angiographic collaterals. Four of the 23 patients progressed to completed stroke despite an angiographically successful revascularization procedure. None of the patients developed hemorrhagic transformation following the procedure.
No patients from these cohorts were lost to follow-up.
Overall Patency
The graft patency rate at 6 weeks was 98% (95% CI; 95.0-99.7%) for arterial pedicle bypass and 93% (95% CI; 87.4-96.0%) for vein bypass (Figure 1 ). Most graft failures occurred within the first week following surgery. Bypass patency was similar for the 2 groups beyond the first week. For arterial pedicle bypasses that were patent at 1 week, the 6-week and 6-month patency was 99%. Two arterial pedicle STA grafts were found to be occluded in a patient with moyamoya disease 4 years after the surgery. For cases where a vein bypass was patent at 1 week, the 6-week and 6-month patency rate was 99% (Figure 1 ). There was no significant statistical difference between the 2 procedures in early, late, and overall patency ( Table 2) .
NEUROLOGICAL OUTCOME POST-BYPASS SURGERY
Three patients (1.7%; 95% CI, 0.4-5.1%) suffered a downgrade in function (mRS . 1) as a complication of arterial pedicle bypass Copyright © Congress of Neurological Surgeons. Unauthorized reproduction of this article is prohibited.
surgery (Table 1 ). This included 1 patient who died. Twelve patients (7.9%; 95% CI, 4.5-13.4%) suffered a downgrade in function (mRS . 1) as a complication of vein bypass surgery (Table1). This included 6 patients who died.
The mechanism for the perioperative death in the case of the arterial pedicle graft was pontine infarction in a patient undergoing STA-MCA bypass for ICA occlusion; this patient also had pre-existing basilar artery occlusion. The mechanism for the perioperative morbidity leading to a downgrade to a mRS of 2 in the case of the arterial pedicle graft was ischemic infarction within the territory of intended graft protection.
The mechanisms for early postoperative deaths in the vein bypass group were occlusion of the bypass and hemispheric infarction in 5 patients and a delayed rupture of the ICA at the anastomosis site in 1 patient. The case of perioperative morbidity leading to a downgrade to an mRS of 3 was a patient treated for a giant MCA aneurysm who developed infarction in the distribution of the lenticulostriate artery territory from MCA thrombosis proximal to the aneurysm trapping. Five patients experienced a downgrade to an mRS of 2 due to surgery: 1 case Possible stroke in evolution is assessed to be the case during the course on an operation where a vessel needs to be sacrificed (eg, during a repair of an aneurysm the vessel requires sacrifice) and it is suspected that the native collaterals would be insufficient to prevent infarction (eg, a failed test balloon occlusion or poor radiological collaterals).
each of an embolus to the MCA; vasospasm; infarction from embolus to the posterior cerebral artery (via a fetal posterior communicating artery); and borderzone infarction related to the cross-clamp period of 38 minutes.
No patient suffered an adverse outcome due to hemorrhagic conversion.
DISCUSSION
The present study of 294 patients with 330 bypasses constitutes a series of patients with cerebrovascular bypass grafts. Although our primary interest in this report is long-term patency, we included our early postoperative periods for comparison. However, the variation in indications for surgery makes comparison of early postoperative outcomes problematic, in that it rarely arises that a patient is considered equally suitable for either procedure. Our preference always is to perform arterial pedicle graft, if deemed appropriate. When we have used an interposition venous conduit, it usually is because no arterial pedicle was suitable (eg, previously occluded CCA and ECA, or insufficient length of the STA for bypass to the PCA).
The present results are in significant contrast to the widespread belief that saphenous vein grafts have a poor long-term patency. 7, 8 For patients in the arterial pedicle bypass group, the patency is 99%. Furthermore, if the arterial pedicle graft was patent at 1 week after surgery, the graft was patent in 99% of cases at 6 weeks and 6 months after surgery. For the vein bypass group, the patency was 93%. However, if the vein bypass was patent at 1 week, the graft was patent in 99% of cases at 6 weeks and 6 months after surgery. The venous bypass with longest follow-up remains patent at more than 16 years. With respect to long-term patency, our series results are favorable compared with those of other series using both the traditional approach to vein bypass surgery and the new innovative nonocclusive bypass surgeries. Sekhar and colleagues 17 reported early and late graft patency of 95% and 94%, respectively, with traditionally performed vein bypass surgery. The new innovative procedures of excimer laserassisted nonocclusive extracranial-to-intracranial bypasses have been reported to have a 92% early patency rate and 77% patency rate at 1 month. 10 However, these differences may be related to patient selection rather than differences in technique. Variation in long-term outcomes between our results and other institutional experiences may reflect differences in case selection. Case selection influences the pressure gradients across the anastomosis sites, and these pressure gradients determine the velocity of flow. A sufficient velocity of flow within the venous conduit is required to prevent thrombosis.
The relatively low procedure-related complication rate for arterial pedicle bypass surgery reinforces this graft's suitability for patients with evidence of chronic cerebral hemodynamic insufficiency in cases where blood flow can be incrementally augmented over time with the arterial pedicle graft enlargement. Our results are in keeping with the international EC/IC Bypass Study Group. 1 The relatively high procedure-related complication rate of 8% in vein bypass cases (half of whom died) suggests this bypass should be reserved for those patients with ominous natural pathological history, failed medical therapy, no viable endovascular option, and no other alternative strategies that deliver a high blood flow. We believe that the low hemorrhagic transformation rate that we report for vein bypass surgery is due to the avoidance of retraction during the cross-clamp period as well as careful attention to blood pressure management as soon as flow is established through the bypass.
Changes in approach over the years of this analysis in our unit have been the greater use of endovascular means for managing stenotic disease and a greater reluctance to attempt bypass in the presence of stroke in evolution. Endovascular techniques have become the first-line treatment option for stenosis (either atheromatous or dissection related) of the ICA and the vertebrobasilar system. However, for stenotic disease of the MCA or occluded symptomatic arteries, we will continue to consider bypass surgery a reasonable option. The patient with acute stroke seldom is considered for bypass surgery with large-caliber bypass because of the almost certain need for the use of a retractor on the already ischemic brain.
CONCLUSION
We report arterial pedicle grafts and vein bypass with large conduit patency for an average 30 months after surgery showing favorable results in long-term patency in both intracranial arterial pedicle grafts and intracranial vein bypass. The long-term patency for saphenous vein grafts is much better than previously reported.
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